In a pregnant women with heart disease, all the following are to be done except.
The core concept here is managing heart disease during pregnancy. I need to recall the standard protocols. During pregnancy, the cardiovascular system undergoes significant changes, like increased blood volume and cardiac output. So, managing a woman with pre-existing heart disease requires monitoring these changes and preventing complications.
The question asks which action is NOT done. Let's think about typical management steps. For example, they might monitor fetal growth, check maternal cardiac status regularly, maybe use certain medications. But what's not done? Maybe something like using certain drugs that are contraindicated in pregnancy, or avoiding specific procedures.
Wait, the correct answer is given as "D. Administration of ACE inhibitors in the second trimester." That makes sense because ACE inhibitors are teratogenic in the second and third trimesters, causing fetal renal damage and other issues. So, that's a classic contraindication. So the correct answer is D.
Now, the other options might be things like regular echocardiograms, administering beta blockers if needed, or using low-dose aspirin. Those are standard. So the incorrect options would be the ones that are actually done, and D is the exception.
For the clinical pearl, it's important to remember that ACE inhibitors are contraindicated in pregnancy, especially after the first trimester. That's a high-yield fact for exams. So the pearl would be to avoid ACE inhibitors in pregnancy beyond the first trimester due to teratogenic effects.
Let me structure the explanation. Core concept: management of heart disease in pregnancy includes avoiding teratogenic drugs. Correct answer is D because ACE inhibitors are harmful. The wrong options are other management steps that are done. Clinical pearl: remember ACE inhibitors are contraindicated in second trimester.
I need to make sure each section is concise and fits the character limit. Also, check that each wrong option is explained briefly. Let me verify the reasoning again. ACE inhibitors are indeed contraindicated in pregnancy after the first trimester. Other options might include correct measures like monitoring, using beta blockers, etc. So the explanation should cover that.
**Core Concept**
Pregnancy increases cardiac workload, necessitating careful management of heart disease. Medications like ACE inhibitors are contraindicated due to teratogenic risks, while others (e.g., beta-blockers) are used for maternal cardiac stability.
**Why the Correct Answer is Right**
ACE inhibitors (e.g., lisinopril) cause fetal renal dysplasia, oligohydramnios, and skull hypoplasia when used in the second/third trimester. They are absolutely contraindicated in pregnancy beyond the first trimester. This aligns with WHO and ACOG guidelines.
**Why Each Wrong Option is Incorrect**
**Option A:** Regular echocardiography is vital to monitor maternal cardiac function during pregnancy.
**Option B:** Low-dose aspirin is recommended in high-risk pregnancies to prevent preeclampsia.
**Option C:** Beta-blockers (e.g., metoprolol